The carcinogenicity of acrylamide

Area of Science:

• Toxicology
• Carcinogenesis
• Epidemiology

Background:

• Acrylamide is a known carcinogen in rodents, inducing tumors across multiple organ sites.
• Metabolic conversion to glycidamide, a reactive epoxide, is implicated in acrylamide's carcinogenicity.
• Existing human studies on acrylamide exposure and cancer risk have yielded inconsistent results.

Purpose of the Study:

• To review the carcinogenic potential of acrylamide in experimental animals.
• To evaluate the evidence for increased cancer risk in humans occupationally or environmentally exposed to acrylamide.
• To assess the role of glycidamide in acrylamide-induced carcinogenesis.

Main Methods:

• Review of rodent bioassays demonstrating acrylamide's carcinogenicity.
• Analysis of epidemiological studies on occupationally exposed workers and general populations.
• Examination of metabolic pathways converting acrylamide to glycidamide.

Main Results:

• Acrylamide induced tumors in mice (lung, skin) and rats (mesotheliomas, thyroid, mammary, brain, adrenal, pituitary, oral, uterine).
• Human studies showed no consistent evidence of increased cancer risk, though a doubled risk for pancreatic cancer was noted in highly exposed workers.
• Retrospective analyses found no causal link between dietary acrylamide and various cancers, suggesting no major risks in Western diets.

Conclusions:

• Acrylamide is a multi-site carcinogen in rodents.
• Epidemiological data currently do not support a significant increase in cancer risk for humans from typical dietary acrylamide exposure.
• Further research, including bioassays of glycidamide, is warranted to fully understand acrylamide's carcinogenic mechanisms and human health implications.